CK1α Degrader

N/A

Report date: 2024/11/06 14:44:27
NME

Base Information

Drug NameCK1α Degrader
Drug Alias NameN/A
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionCasein kinase I isoform alpha degraders
TargetsCasein kinase I isoform alpha
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A